Brineura listed on PBS for Batten Disease

Children with the rare neurological condition Neuronal Ceroid Lipofuscinosis Type-2 (CLN 2), also known as Batten Disease, will have subsidised access to cerliponase alfa (Brineura) on the PBS from 1 May 2019. Announced as part of the Federal Budget, the treatment was recommended for listing on the PBS by the Pharmaceutical Benefits Advisory Committee in ...

Already a member?

Login to keep reading.

© 2021 the limbic